glp-1 oral supplement Support FDA approves Lilly's Foundayo™ (orforglipron),
Description
A 52 weeks, controlled trial, investigated the efficacy of GLP-1RAs of liraglutide (1.2 and 1.8 mg/day) vs
others discontinue if GLP-1 provides adequate control
The genetic test ($99 add-on after first month) is not pharmacogenomic testing
Supporting Mental Health Emerging research has revealed a critical gut-brain connection
doi:10.1001/jamanetworkopen.2022.31982 Kalas MA, Galura GM, McCallum RW
